IP Library Granted Patent US 7,332,200
Granted Patent B1
US 7,332,200 · App. 10/019,837 · Granted Feb 19, 2008

Permeabilizing biofilms

Assignee: The General Hospital Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,332,200
App. No.
10/019,837
Granted
Feb 19, 2008
Kind
B1
Abstract

Methods for permeabilizing biofilms using stress waves are described. The methods involve applying one or more stress waves to a biofilm, e.g., on a surface of a device or food item, or on a tissue surface in a patient, and then inducing stress waves to create transient increases in the permeability of the biofilm. The increased permeability facilitates delivery of compounds, such as antimicrobial or therapeutic agents into and through the biofilm.

Claims (29)

1. A method of delivering a compound into a matrix of a biofilm, the method comprising:

(a) contacting the biofilm with the compound and a coupling medium;

(b) contacting the coupling medium with a target; and

(c) causing the target to propagate a sufficient number of stress waves into the biofilm to increase the permeability of the biofllm, thereby enabling the compound to pass into the matrix of the biofilm.

2. The method of claim 1 , wherein at least one of the stress waves is a broad-band compressive wave having a rise time of at least 500 ps and a peak pressure of at least 50 bar.

3. The method of claim 1 , wherein the stress wave has a peak pressure of 550-650 bar.

4. The method of claim 1 , wherein the stress wave has a rise time of about 10-100 ns.

5. The method of claim 1 , wherein the stress wave is generated by exposing the target material to a pulsed laser beam.

6. The method of claim 5 , wherein the laser beam has a wavelength between about 140 nm and about 12 μm.

7. The method of claim 5 , wherein a transparent material is bonded to a surface of the target material.

8. The method of claim 5 , wherein the target material is selected from a group consisting of a metal foil, a plastic, and an energetic material.

9. The method of claim 8 , wherein the metal foil comprises a metal selected from a group consisting of aluminum and copper.

10. The method of claim 5 , wherein the target material comprises a polymer.

11. The method of claim 5 , wherein the target material comprises polystyrene.

12. The method of claim 5 , wherein the target material comprises a material that absorbs laser energy, and wherein the stress wave is generated by laser-induced heating of the absorbing material.

13. The method of claim 1 , wherein the compound comprises an antimicrobial agent.

14. The method of claim 1 , wherein the biofilm comprises one or more bacteria or products thereof.

15. The method of claim 1 , wherein the biofilm comprises one or more bacterial capsular polysaccharides.

16. The method of claim 1 , wherein the biofilm comprises a microorganism or product thereof selected from the group consisting of an Actinomycete spp. or a product thereof, A. viscosus or a product thereof, or P. gingivalis or a product thereof.

17. The method of claim 1 , wherein the biofilm comprises one or more fungi or products thereof.

18. The method of claim 1 , wherein the biofilm comprises one or more protozoa or products thereof.

19. The method of claim 1 , wherein the compound and the coupling medium is provided in a reservoir, wherein the reservoir is arranged to enable the coupling medium to directly contact a surface of the biofilm.

20. The method of claim 19 , wherein the coupling medium further comprises a surfactant.

21. The method of claim 20 , wherein the surfactant is sodium lauryl sulfate.

22. The method of claim 1 , wherein the biofilm contacts an enamel surface, a periodontal pocket, a tracheal surface, or an internal organ surface of a mammal.

23. The method of claim 22 , wherein the mammal is a human.

24. The method of claim 1 , wherein the compound comprises an antimicrobial agent, and wherein the agent is delivered into the matrix of the biofilm by contacting the biofilm with the antimicrobial agent, and exposing the target material disposed on the biofilm to a pulsed laser beam, thereby propagating one or more stress waves through the biofllm contacting the antimicrobial agent, thereby causing the antimicrobial agent to enter the matrix.

25. A method of treating disorders associated with a biofilm, the method comprising exposing a target coupled to the biofilm via a coupling medium to one or more stress waves sufficient to propagate into and permeabilize the biofilm, and then delivering a therapeutic agent into a matrix of the biofilm, thereby treating the disorder associated with the biofilm.

26. The method of claim 25 , wherein the therapeutic agent comprises an antimicrobial agent.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 1, 2020
From: MASSACHUSETTS GENERAL HOSPITAL
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 053103/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2007
From: SOUKOS, NIKOLAOS S.; LEE, SHUN; DOUKAS, APOSTOLOS G.
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 020165/0459 →
CONFIRMATORY LICENSE Recorded Feb 17, 2004
From: MASSACHUSETTS GENERAL HOSPITAL
To: ENGERY, UNITED STATES DEPARTMENT OF
Reel/Frame 014976/0129 →
Continuity (1)
Provisional Application 6013373000 · May 12, 1999